First Hemophilia B Patient Enrolled in Potential Breakthrough Phase III Trial

According to BioPortfolio, the company UniQure has recently announced that the first hemophilia B patient has been enrolled in their Phase III study of the treatment AMT-061, which is an…

Continue Reading First Hemophilia B Patient Enrolled in Potential Breakthrough Phase III Trial
Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
JoshMB / Pixabay

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…

Continue Reading Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis
source: pixabay.com

Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis

According to a story from sciencedaily.com, recent research has revealed the mechanism that causes hypokalemic periodic paralysis, a rare condition that causes patients to experience sudden, severe muscle weakness. The…

Continue Reading Scientists Have Discovered a Mechanism Behind Hypokalemic Periodic Paralysis
Unraveling the Mysteries of Familial Mediterranean Fever Led to a Career of Rare Disease Research
FotoshopTofs / Pixabay

Unraveling the Mysteries of Familial Mediterranean Fever Led to a Career of Rare Disease Research

According to a story from govloop.com, Dr. Daniel Kastner, the Scientific Director for the Division of Intramural Research at the National Institutes of Health (NIH), has committed his career to…

Continue Reading Unraveling the Mysteries of Familial Mediterranean Fever Led to a Career of Rare Disease Research
A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients
Bru-nO / Pixabay

A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients

A researcher from the University of Alabama at Birmingham is working on how to improve treatment for patients with status epilepticus. The original article can be read here, at UAB…

Continue Reading A Researcher is Looking Into How Long Artificial Comas Should Last For Status Epilepticus Patients
The Results of a Pivotal Study of Tegsedi For The Treatment of hATTR Amyloidosis With Polyneuropathy Have Been Published
Source: Pixabay

The Results of a Pivotal Study of Tegsedi For The Treatment of hATTR Amyloidosis With Polyneuropathy Have Been Published

The final results from a study of the experimental drug tegsediTM (inotersen) for the treatment of patients with hereditary ATTR amyloidosis with polyneuropathy have been published. The original article can be…

Continue Reading The Results of a Pivotal Study of Tegsedi For The Treatment of hATTR Amyloidosis With Polyneuropathy Have Been Published

ICYMI: Orphan Drug Designation Has Been Awarded to a Drug Being Developed to Treat Sickle Cell Disease

The experimental drug olinciguat (IW-1701) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of sickle cell disease. The full article can…

Continue Reading ICYMI: Orphan Drug Designation Has Been Awarded to a Drug Being Developed to Treat Sickle Cell Disease